Hasholzner U - Search Results

1

Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.

Meier W, Stieber P, Hasholzner U, Baumgartner L, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):2959-62. Anticancer Res. 1997. PMID: 9329575

2

Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.

Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A. Hasholzner U, et al. Anticancer Res. 1994 Nov-Dec;14(6B):2743-6. Anticancer Res. 1994. PMID: 7532929

3

CYFRA 21-1. A new marker in lung cancer.

Stieber P, Hasholzner U, Bodenmüller H, Nagel D, Sunder-Plassmann L, Dienemann H, Meier W, Fateh-Moghadam A. Stieber P, et al. Among authors: hasholzner u. Cancer. 1993 Aug 1;72(3):707-13. doi: 10.1002/1097-0142(19930801)72:3<707::aid-cncr2820720313>3.0.co;2-x. Cancer. 1993. PMID: 7687515

4

Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgery.

Meier W, Stieber P, Hasholzner U, Gropp M, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):2945-7. Anticancer Res. 1997. PMID: 9329571

5

Significance of tumor marker determinations in the primary therapy of ovarian cancer.

Meier W, Baumgartner L, Stieber P, Hasholzner U, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):2949-51. Anticancer Res. 1997. PMID: 9329572

6

CA125 based diagnosis and therapy in recurrent ovarian cancer.

Meier W, Baumgartner L, Stieber P, Hasholzner U, Fateh-Moghadam A. Meier W, et al. Among authors: hasholzner u. Anticancer Res. 1997 Jul-Aug;17(4B):3019-20. Anticancer Res. 1997. PMID: 9329590

7

Value of HAMA--determination in clinical practice--an overview.

Hasholzner U, Stieber P, Meier W, Lamerz R. Hasholzner U, et al. Anticancer Res. 1997 Jul-Aug;17(4B):3055-8. Anticancer Res. 1997. PMID: 9329600 Review.

8

Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.

Stieber P, Dienemann H, Hasholzner U, Müller C, Poley S, Hofmann K, Fateh-Moghadam A. Stieber P, et al. Among authors: hasholzner u. Eur J Clin Chem Clin Biochem. 1993 Oct;31(10):689-94. doi: 10.1515/cclm.1993.31.10.689. Eur J Clin Chem Clin Biochem. 1993. PMID: 7507359

9

Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.

Stieber P, Bodenmüller H, Banauch D, Hasholzner U, Dessauer A, Ofenloch-Hähnle B, Jaworek D, Fateh-Moghadam A. Stieber P, et al. Among authors: hasholzner u. Clin Biochem. 1993 Aug;26(4):301-4. doi: 10.1016/0009-9120(93)90129-t. Clin Biochem. 1993. PMID: 7694815

10

Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma.

Hasholzner U, Baumgartner L, Stieber P, Meier W, Reiter W, Pahl H, Fateh-Moghadam A. Hasholzner U, et al. Int J Cancer. 1996 Aug 22;69(4):329-34. doi: 10.1002/(SICI)1097-0215(19960822)69:4<329::AID-IJC16>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8797878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters